Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2000 May 9;97(10):5317–5321. doi: 10.1073/pnas.97.10.5317

Permanence or change? The meaning of genetic variation

Francisco M Salzano 1,*
PMCID: PMC25826  PMID: 10805790

Abstract

Selected aspects of the evolutionary process and more specifically of the genetic variation are considered, with an emphasis in studies performed by my group. One key aspect of evolution seems to be the concomitant occurrence of dichotomic, contradictory (dialect) processes. Genetic variation is structured, and the dynamics of change at one level is not necessarily paralleled by that in another. The pathogenesis-related protein superfamily can be cited as an example in which permanence (the maintenance of certain key genetic features) coexists with change (modifications that led to different functions in different classes of organisms). Relationships between structure and function are exemplified by studies with hemoglobin Porto Alegre. The genetic structure of tribal populations may differ in important aspects from that of industrialized societies. Evolutionary histories also may differ when considered through the investigation of patrilineal or matrilineal lineages. Global evaluations taking into consideration all of these aspects are needed if we really want to understand the meaning of genetic variation.

Conservatives and Revolutionaries

In the interpretation of our existence two philosophies can be distinguished, one that places emphasis on stability, in the maintenance of the status quo, and another that emphasizes the importance of change. It is not unrealistic to relate these two positions to the biological constitution of the individuals who maintain them. Obviously, there are no specific hereditary factors for conservatism or revolutionary tendencies. But the psychic makeup of all of us is undoubtedly influenced by genes, through the structure and functioning of the neuro-endocrine system.

An example may be in order here: maybe there is not, in all human society, an institution as conservative as the Catholic church; but its officials always have had to worry about rebels, for instance, Pierre Teilhard de Chardin or the Brazilian Leonardo Boff. And although Saint Augustine (354–430 AD) cannot be classified as a rebel, he favored an allegoric interpretation of the Bible's book of Genesis and developed an evolutionary concept, which included organic and inorganic matter, as opposed to a special creation.

Changes: Nonbiological and Biological

The universe is not static. Edwin Hubble (1889–1953) was the person responsible for the definitive denial of such a monotonous idea. His observations led to the conclusion that we live in a world in expansion, with the galaxies moving away from each other.

A special type of change is the evolutionary modification. The word evolution derives from the Latin term evolutio and its literal meaning is an unrolling. It can be used in this and other senses that involve the idea of change. But not all change is evolutionary. There is ceaseless change in the ocean surface, but it is not an evolutionary process. Implicit in the evolution concept are those of: (a) continuous change, (b) divergence, (c) restriction of opportunities, and (d) in a large number of situations, irreversibility. Presently there are doubts whether there is a general direction for the organic evolutionary process or progress in it. In relation to this last point, the key problem is, of course, the definition of progress. To many it would be intimately connected with the adaptation concept, but there are discordant views. Those critics argue that the examples chosen constitute a posteriori explanations, incapable of predicting future tendencies (1).

The most accepted theory about the origin of the universe maintains that in the beginning all matter would be concentrated in a single point, with a density approaching infinity. Twenty billion years ago a marvelous explosion (the Big Bang) put in motion all of the evolutionary process.

The second chapter of the “Book of the Universe” has to do with the origin of life. Life in our planet should have begun some 3.5 billion years ago. Because our solar system, and with it the Earth, originated approximately 4.5 billion years ago, it is possible to conclude that life appeared relatively soon in our planet's history.

Evolutionary Transitions

Periodically, along the evolutionary process, a new event completely revolutionize the field, opening ample horizons for further changes. Some of these events, in the general history of the organisms, as well as more specifically in animals, are listed in Table 1. It is impossible here, because of space limitations, to consider each of them in detail. It is clear, however, that these developments simultaneously evoke new ways of change, but also restrict them to a certain direction.

Table 1.

The evolutionary transitions

General stages, previous General stages, subsequent
Replicating molecules Populations of molecules in compartments
Independent replicators Chromosomes
RNA as gene and enzyme DNA + protein (genetic code)
Prokaryotes Eukaryotes
Asexual clones Sexual populations
Protists Animals, plants, fungi (cell differentiation)
Solitary individuals Colonies (nonreproductive castes)
Primate societies Human societies (language)
Animal development
 1.  Multicellularity (cell layers, cell adhesion, spatially controlled patterns of differentiation)
 2.  Defined axes of symmetry (species-specific body shape, structural repetition, origin of neurons, inner and outer epithelial germ layers)
 3.  Conversion of a two-germ layer body plan into a three-germ layer body plan
 4.  Inversion of dorsoventral patterning systems
 5.  Origin of vertebrates, new strategies for deploying cells in development
 6.  Invention of migratory lateral mesodermal cells, origin of two sets of patterned paired appendages, and anteroposterior diversification of the cranial visceral arches

Sources: Maynard Smith and Szathmáry (2); Holland (3). 

As a matter of fact, evolution can be viewed as a series of opposing, dichotomic, contradictory processes (4), and a list of some of these dialectical relationships is provided in Table 2.

Table 2.

Dialectical relationships in the evolutionary process

 1.  Chaos and antichaos
 2.  Matter and energy
 3.  Inorganic and organic
 4.  Unicellularity and multicellularity
 5.  Immortality and mortality
 6.  DNA and protein
 7.  Nucleus and cytoplasm
 8.  Asexual and sexual reproduction
 9.  r and K selection
10.  Nonsocial and social
11.  Aggression and cooperation
12.  Nonhumans and humans
13.  Biology and culture
14.  Ecological success and dominance
15.  Nonethics and ethics
16.  Freedom and organization

Source: Salzano (5). 

Biological Variation

The most conspicuous property of the variation found in living organisms is that it is structured. At least theoretically we could envisage a world in which all forms of life would be parts of an immense continuum and not separated in reproductively isolated species as is true now. There are reasons for such constraints. An evolutionary unit must be sufficiently cohesive, so that it could successfully meet the challenges of its biotic and physical environments. This can be accomplished in a variety of ways. For instance, the genetic material can be organized in semi-independent arrays. In plants no fewer than three classes of genomes can be characterized, arranged as nuclear, mitochondrial, and chloroplastic DNA. In animals only the two first genomes coexist (in humans they consist of 3,300 mega bp of nuclear DNA, and 16.6 kb of mtDNA). Variability at the nuclear DNA, mtDNA, and protein levels does not necessarily occur in parallel fashion (6).

With the development of molecular methods, it was possible to verify that the genetic material is highly heterogeneous, with coding and noncoding (regulatory) regions, segments of highly or moderate repetitive DNA, and remnants of past insertion events. The variability to be expected in these dissimilar structures is highly diverse. In some regions change is partially or completely forbidden, because it would impair functions or would be incompatible with life. In others it could be inconsequential (although probably there is no such a thing as a completely neutral mutation); whereas in some limited cases it could be favored.

Common variants (polymorphisms) can occur in a number of ways. The most frequent, in the human genome, are single base pair differences, also called single-nucleotide polymorphisms (SNPs). It is estimated that the complete human sequence will reveal at least one million SNPs (7). But other types of sequence variation occur, such as copy number changes, insertions, deletions, duplications, and rearrangements. Each of them has specific dynamics related to the origin, maintenance, and eventual loss of variation, which should be taken into account in any balanced general evaluation. According to the methods of study these variants are labeled as (a) restriction fragment length polymorphisms, (b) insertion/deletion (Alu) polymorphisms, (c) variable number of tandem repeats or minisatellites, and (d) short tandem repeats or microsatellites.

From the 1950s to the 1970s much discussion occurred about the genetic structure of organisms (see, for instance, ref. 8). One key point was the proportion of heterozygous, as compared with homozygous, regions a given species could afford. Answers now can start to be made by using direct molecular techniques. Using a set of 8,000 short tandem repeats polymorphisms, Broman and Weber (9) verified in several families average largest homozygous segments greater than 10 cM, even among “outbred” individuals from Utah and Venezuela.

Another question relates to units of selection. As far as the human immune defenses mechanisms are concerned, the process of lymphocyte diversity generation and subsequent clonal selection is fundamentally Darwinian. Much can be learned, therefore, about evolutionary processes within individuals (10). Bosch et al. (11), on the other hand, considering 11 biallelic polymorphisms and seven short tandem repeat human Y chromosome markers, asserted that “A population may be better understood as an association of lineages from a deep and population-independent gene genealogy, rather than as a complete evolutionary unit.”

From the bare DNA until the formation of a fully grown individual there is a long way; variability in the processing and translation of DNA into protein also should be taken into consideration when comparisons at different levels of the biological hierarchy are considered.

The genes' vehicles in the intergeneration transfer of genetic information are the chromosomes, and here again the coupling of molecular with traditional chromosome methods, plus comparative gene mapping, is opening new ways in the investigation of evolution. Present-day DNA probes allow a resolution of up to 10–15 mega bp for chromosome subregions, and using these techniques it was possible to establish that the equivalent to chromosomes 3 and 21 from Homo sapiens formed a syntenic block for all placental mammals, the fission between the two having occurred in Old World primates after the divergence of New World monkeys. Intrachromosomal rearrangements also could be identified (12).

Pathogenesis-Related Proteins (PRs)

As an example of the types of approach that can be developed in the area of genetic variation, I turn now to some unpublished results obtained by L.B. Freitas, S.L. Bonatto, and myself in a particular type of proteins determined by a multigenic family and related to defense mechanisms in plants, but that also occur in fungi and animals (invertebrates and vertebrates, including humans). We have examined the phylogenetic relationships in seven families of these proteins (classified in relation to serology, molecular weights, and similarity in amino acid sequences). Within-family comparisons involved 79 plant species, 166 amino acid sequences, and 1,791 sites. For 37 species, 124 different PR isoforms (that is, those which occur in the same species) have been identified (an average of 3.3 per species). Thirty-one (84%) of those investigated in the 37 species tended to cluster together. Of the 17 clusters distinguished in the seven phylogenetic trees 10 (59%) were in agreement with the species' taxonomic status, ascertained at the family level. The strong similarities among the intraspecific, as compared with the interspecific comparisons, argue for some kind of concerted evolution, but the rare occurrence of widely different isoforms also may suggest diversifying selection.

Species of Passiflora (the passionflower plants) also are being studied by my group considering Betv1 homologous proteins (PR family 10), an intergenic spacer (ITS) located between the trnb and trnF genes of chloroplast DNA, and the ITS1 and ITS2 of ribosomal DNA. As was found with humans (6), agreement between systems was only partial.

These proteins exemplify the dialectical relationship indicated in the title of this paper. Although they may vary widely even within a given plant, they maintain similarities that make possible their classification in a wide “PR protein superfamily.” This set includes fungi (Saccharomyces, Schizophylum) and nematode (Caenorhabditis) proteins; antigen 5, one major vespid venom antigen, and an antigen 5-related protein from Drosophila melanogaster; helothermine, from a lizard venom; mammalian Tpx-1 testis-specific protein and sperm-coating glycoprotein Scg; and human-specific granule protein 28 from neutrophils, P25TI trypsin inhibitor of neuroblastoma and glioblastoma cells, and glioma pathogenesis-related GliPr. The latter, specifically, shows a remarkable molecular similarity to tomato's PR14a protein (13).

β-Globin Changes in the Latin American Microcosm

No fewer than 485.85 million persons live in Latin America, distributed over an area of 21.25 million km2. They present a dazzling morphological variability, conditioned by the varied contribution of their founders. Many studies were conducted in this area, and presently Maria Catira Bortolini and myself are preparing a book describing as comprehensively as possible all aspects related to the genetics and evolution of Latin Americans.

Table 3 lists 41 variants (besides the common S and C types) observed in the β chain of Hb in Middle and South America. The mutations found are distributed all over the molecule, from position 2 to position 136. Some of them lead to abnormal characteristics, as listed, and their geographical distribution is uneven. Some occur in one country only, whereas HbE (which is polymorphic in Asian populations) and D-Punjab are more widespread, having been found in subjects from eight nations.

Table 3.

Beta-Hb variants observed in Latin América

Variant Substitution Abnormal characteristics Country
Deer Lodge 2 His→Arg ↑O2 affinity Venezuela
HbS-Antilles 6 Glu→Val + 23 Val→Ileu Sickling Martinique
G-San José 7 Glu→Gly Slightly unstable Mexico
Siriraj 7 Glu→Lys Martinique
Rio Grande 8 His→Thr Mexico
Porto Alegre 9 Ser→Cys ↑O2 affinity, tendency to polymerize Argentina, Brazil, Cuba, Venezuela
J-Baltimore 16 Gly→Asp Brazil, Colombia, Guadeloupe, Martinique, Mexico, Trinidad
Alamo 19 Asn→Asp Cuba, Venezuela
D-Iran 22 Glu→Gln Guadeloupe, Jamaica
E 26 Glu→Lys Brazil, Costa Rica, Cuba, Guadeloupe, Jamaica, Martinique, Mexico, Surinam
Knossos 27 Ala→Ser Affects synthesis Martinique
Genova 28 Leu→Pro Unstable Cuba
Bucuresti 42 Phe→Leu Unstable; ↓O2 affinity Cuba
Willamette 51 Pro→Arg Unstable; ↓O2 affinity Cuba, Venezuela
Osu Christiansborg 52 Asp→Asn Jamaica
Ocho Rios 52 Asp→Ala Jamaica
Dhofar 58 Pro→Arg Jamaica
Zürich 63 His→Arg Unstable; ↓O2 affinity Brazil
I-Toulouse 66 Lys→Glu Unstable; Fe+3 Cuba
Korle-Bu 73 Asp→Asn ↓O2 affinity Colombia, Costa Rica, Cuba, Guadeloupe, Jamaica, Martinique, Panama, Venezuela
J-Chicago 76 Ala→Asp Venezuela
Costa Rica 77 His→Arg Costa Rica
Buenos Aires 85 Phe→Ser Unstable; ↑O2 affinity Argentina
Santa Ana 88 Leu→Pro Unstable Brazil, Cuba
Roseau-Pointe a Pitre 90 Glu→Gly Slightly unstable ↓O2 affinity Guadeloupe
Caribbean 91 Leu→Arg Slightly unstable ↓O2 affinity Jamaica
N-Baltimore 95 Lys→Glu Brazil, Cuba, El Salvador, Guadeloupe, Martinique
J-Cordoba 95 Lys→Met ↓O2 affinity Argentina
Köln 98 Val→Met Unstable Brazil
Mainz 98 Val→Glu Unstable Brazil
Camperdown 104 Arg→Ser Unstable Brazil
New York 113 Val→Glu Slightly unstable ↓O2 affinity Costa Rica
Fannin-Lubbock 119 Gly→Asp Slightly unstable Mexico
Riyadh 120 Lys→Asn Mexico
D-Punjab 121 Glu→Gln ↓O2 affinity Argentina, Brazil, Cuba, Guadeloupe, Jamaica, Martinique, Mexico, Venezuela
O-Arab 121 Glu→Lys Jamaica, Martinique, Puerto Rico
Hofu 126 Val→Glu Unstable Peru, Venezuela
J-Guantanamo 128 Ala→Asp Unstable Chile, Cuba
K-Woolwich 132 Lys→Gln Brazil, Dominica, Guadeloupe, Jamaica, Martinique
North Shore-Caracas 134 Val→Glu Unstable Venezuela
Hope 136 Gly→Asp Unstable ↓O2 affinity Cuba, Martinique

Sources: Refs. 3165

One of these Hb types (Hb Porto Alegre) was discovered by my group, in a family of Portuguese descent living in the indicated city (14). In that first report it was suggested that the change in the molecule would lead to polymerization in vitro, but that this process would not occur in vivo, the mutation, therefore, resulting in a “silent” phenotype. Four years later the molecular change responsible for the new type was identified (15). Cysteine substitutes serine at the ninth residue of the chain; because this sulfhydryl group is on the surface of the molecule, intermolecular disulfide bonds are allowed to form. Subsequent studies identified this Hb type in four other Brazilian populations (Coari, Belém, Natal, Campinas), in Buenos Aires (two carriers of Spanish descent), and in Havana (one carrier of Portuguese and one of Spanish origin) (1621). In Buenos Aires one of the carriers also had beta thalassemia, and in Campinas Hb Porto Alegre was found associated with Hb Santa Ana, an unstable Hb. These findings emphasize that the change in Hb Porto Alegre does not lead to clinical problems (because it can coexist with abnormal variants). The lack of polymerization in vivo is probably because of a compensatory synthesis of glutathion reductase (18, 22). Casemiro V. Tondo (23, 24) used Hb Porto Alegre as a model for different types of biophysical and biochemical investigations and was able to demonstrate that in vitro bloods of homozygotes form dodecamers and that the tetramer formed in the material from heterozygotes is asymmetric.

Tribal Life

Previous genetic work by our group in South American Indians has been reviewed at regular intervals (for instance, refs. 6 and 25) and therefore I am not going to re-examine it here except for one aspect. It refers to our demographic and genetic studies among the Xavante Indians. They are unusual in relation to other tribal groups, because one of their populations (São Domingos, also called Rio das Mortes or Etéñitépa) has been closely followed for nearly half a century. Genetic information was obtained both in the 1960s and 1990s, making possible integration with extended genealogies that were collected at regular intervals since 1957.

Tribal life differs from those of agricultural or industrial communities in various ways. The groups are small, behavior of their members is much more regulated by kinship rules, many of them practice polygamy (generally polyginy, one man having simultaneously more than one wife, who frequently are sisters), and mortality is caused mostly by infectious diseases.

It is not yet clear how much these patterns influence genetic variation. Present demographic methods generally are adapted for large populations, without concern to intergeneration effects in fertility or mortality. For evolutionary purposes, however, fitness, that is, the amount of genetic influence one individual contributes to the next generations, is an important parameter. In a polyginous society it would be expected that the average and variability in this parameter would be higher in males than in females. But unpublished analyses made by Sidia M. Callegari-Jacques, Nancy M. Flowers, Nara F.M. Laner, and myself indicates that among the Xavante this is not true. This result probably reflects the fact that in our species both males and females are needed for reproduction and that in this society generally all females are engaged in the reproductive process.

The Ultimate Dichotomy: Sex

Is the comparison between males and females really dimorphic? Blackless et al. (26) argued that 1.7% of all live births in our species do not conform to a platonic ideal of absolute sex chromosome, gonadal, genital, and hormonal dimorphism. Fausto-Sterling (27) even contended that there are five sexes in our species! Exaggerations apart, the fact is that the evolutionary histories among humans, as considered through mtDNA (maternaly inherited) or the Y chromosome (transmitted exclusively by males) are giving different patterns. One reason for these results is that Y chromosome variants tend to be more localized geographically than those of mtDNA and the autosomes. This discrepancy may be caused by the custom of patrilocality, namely, the tendency for a wife to move into her husband's natal household (28).

But there are other differences in the evolutionary histories of men and women. For instance, the mutation rate for the hemophilia B locus among males is 8.6 times higher than that observed among females (29), and the assessment we have made of interethnic admixture in 11 African-derived South American populations based on the mtDNA sequences of the first hypervariable region and one Y chromosome marker (DYS19) showed evidence for asymmetrical unions in relation to sex in nine (82%) of them (30).

Acknowledgments

This research is financed by Programa de Apoio a Núcleos de Excelência (PRONEX), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Financiadora de Estudos e Projetos (FINEP), and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS).

Abbreviation

PR

pathogenesis-related protein

Footnotes

This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected on April 27, 1999.

References

  • 1.Nitecki M H. Evolutionary Progress. Chicago: Univ. of Chicago Press; 1988. [Google Scholar]
  • 2.Maynard Smith J, Szathmáry E. The Major Transitions in Evolution. New York: Freeman; 1995. [Google Scholar]
  • 3.Holland P W H. Am Zool. 1998;38:829–842. [Google Scholar]
  • 4.Levins R, Lewontin R. The Dialectical Biologist. Cambridge, MA: Harvard Univ. Press; 1985. [Google Scholar]
  • 5.Salzano F M. Evolução do Mundo e do Homem: Liberdade ou Organização? Porto Alegre, Brazil: Editora da Universidade Federal do Rio Grande do Sul; 1995. [Google Scholar]
  • 6.Hutz M H, Callegari-Jacques S M, Bortolini M C, Salzano F M. In: Genomic Diversity: Applications in Human Population Genetics. Papiha S S, Deka R, Chakraborty R, editors. New York: Plenum; 1999. pp. 23–32. [Google Scholar]
  • 7.Collins A, Lonjou C, Morton N E. Proc Natl Acad Sci USA. 1999;96:15173–15177. doi: 10.1073/pnas.96.26.15173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Salzano F M. The Role of Natural Selection in Human Evolution. Amsterdam: North–Holland; 1975. [Google Scholar]
  • 9.Broman K W, Weber J L. Am J Hum Genet. 1999;65:1493–1500. doi: 10.1086/302661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.McDade T W, Worthman C M. Am J Hum Biol. 1999;11:705–717. doi: 10.1002/(SICI)1520-6300(199911/12)11:6<705::AID-AJHB1>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  • 11.Bosch E, Calafell F, Santos F R, Pérez-Lezaun A, Comas D, Benchemski N, Tyler-Smith C, Bertranpetit J. Am J Hum Genet. 1999;65:1623–1638. doi: 10.1086/302676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Müller S, Stanyon R, Finelli P, Archidiacono N, Wienberg J. Proc Natl Acad Sci USA. 2000;97:206–211. doi: 10.1073/pnas.97.1.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Szyperski T, Fernández C, Mumenthaler C, Wüthrich K. Proc Natl Acad Sci USA. 1998;95:2262–2266. doi: 10.1073/pnas.95.5.2262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Tondo C V, Salzano F M, Rucknagel D L. Am J Hum Genet. 1963;15:265–279. [PMC free article] [PubMed] [Google Scholar]
  • 15.Bonaventura J, Riggs A. Science. 1967;158:800–802. doi: 10.1126/science.158.3802.800-a. [DOI] [PubMed] [Google Scholar]
  • 16.Seid-Akhavan M, Ayres M, Salzano F M, Winter W P, Rucknagel D L. Hum Hered. 1973;23:175–181. doi: 10.1159/000152570. [DOI] [PubMed] [Google Scholar]
  • 17.Peñalver J A, Miani M S A. Medicina (Buenos Aires) 1974;34:287–292. [PubMed] [Google Scholar]
  • 18.Martínez G, Lima F, Wade M, Estrada M, Colombo B, Heredero L, Granda H. J Med Genet. 1977;14:422–425. doi: 10.1136/jmg.14.6.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Silva M I A F, Salzano F M, Lima F A M. St Phys Anthropol. 1981;7:3–11. [Google Scholar]
  • 20.Rosa V L, Salzano F M, Franco M H L P, Freitas M J M. Rev Bras Genet. 1984;7:569–582. [Google Scholar]
  • 21.Colombo B, Martínez G. Hemoglobin. 1985;9:415–422. doi: 10.3109/03630268508997019. [DOI] [PubMed] [Google Scholar]
  • 22.Tondo C V. Biochem Biophys Res Commun. 1982;105:1381–1388. doi: 10.1016/0006-291x(82)90940-8. [DOI] [PubMed] [Google Scholar]
  • 23.Tondo C V. An Acad Bras Ciênc. 1971;43:651–669. [Google Scholar]
  • 24.Tondo C V. Hemoglobin. 1976/77;1:195–210. doi: 10.3109/03630267608991680. [DOI] [PubMed] [Google Scholar]
  • 25.Salzano F M, Callegari-Jacques S M. South American Indians: A Case Study in Evolution. Oxford: Clarendon; 1988. [Google Scholar]
  • 26.Blackless M, Cheruvastra A, Derryck A, Fausto-Sterling A, Lauzanne K, Lee E. Am J Hum Biol. 2000;12:151–160. doi: 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  • 27.Fausto-Sterling A. Sciences. 1993. March/April, 20–24. [Google Scholar]
  • 28.Seielstad M T, Minch E, Cavalli-Sforza L L. Nat Genet. 1998;20:278–280. doi: 10.1038/3088. [DOI] [PubMed] [Google Scholar]
  • 29.Green P M, Saad S, Lewis C M, Giannelli F. Am J Hum Genet. 1999;65:1572–1579. doi: 10.1086/302651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Bortolini M C, Silva W A, Jr, Castro de Guerra D, Remonatto G, Mirandola R, Hutz M H, Weimer T A, Silva M C B O, Zago M A, Salzano F M. Am J Hum Biol. 1999;11:551–563. doi: 10.1002/(SICI)1520-6300(1999)11:4<551::AID-AJHB15>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  • 31.Arends T, Garlin G, de Perera A P, Castillo O. Hemoglobin. 1984;8:621–626. doi: 10.3109/03630268408991747. [DOI] [PubMed] [Google Scholar]
  • 32.Monplaisir N, Merault G, Poyart C, Rhoda M-D, Craescu C, Vidaud M, Galacteros F, Blouquit Y, Rosa J. Proc Natl Acad Sci USA. 1986;83:9363–9367. doi: 10.1073/pnas.83.24.9363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ruiz Reyes G. Hemoglobin. 1983;7:603–610. doi: 10.3109/03630268309027945. [DOI] [PubMed] [Google Scholar]
  • 34.Monplaisir N, Galacteros F, Arous N, Rhoda M D, Delanoe-Garin J, Ouka-Montjean M, Linval J C, Rosa J. Nouv Rev Franç d'Hématol. 1985;27:11–14. [PubMed] [Google Scholar]
  • 35.Sáenz G F, Rodríguez Romero W, Chaves Villalobos M. Rev Biol Trop. 1993;41:393–403. [PubMed] [Google Scholar]
  • 36.Arends T. New Zeal Med J. 1966;65,Suppl.:831–844. [Google Scholar]
  • 37.Fabritius H, Millan J, Blot M, Rivat P, Charles-Gervais J, Lacroix H, Le Corroller Y. Nouv Rev Franç d'Hématol. 1980;22:243–248. [PubMed] [Google Scholar]
  • 38.Sáenz G F. Rev Biol Trop. 1988;36:361–372. [PubMed] [Google Scholar]
  • 39.Colombo B, Martínez G. Hemoglobin. 1985;9:415–422. doi: 10.3109/03630268508997019. [DOI] [PubMed] [Google Scholar]
  • 40.Arends T, Castillo O, Garlin G, Maleh Y, Anchustegui M, Salazar R. Hemoglobin. 1987;11:135–138. doi: 10.3109/03630268709005787. [DOI] [PubMed] [Google Scholar]
  • 41.Serjeant G R, Serjeant B E, Forbes M, Hayes R J, Higgs D R, Lehmann H. Br J Haematol. 1986;64:253–262. doi: 10.1111/j.1365-2141.1986.tb04117.x. [DOI] [PubMed] [Google Scholar]
  • 42.Targino de Araújo J, Ribeiro V S, Costa e Silva M S, de Bonis J C, Targino de Araújo R A. Rev Inst Med Trop. 1982;24:229–233. [PubMed] [Google Scholar]
  • 43.Galacteros F, Garin J D, Monplaisir N, Namoune S, Arous N, Blouquit Y, Mamalaki A, Tulliez M, Ouka M, Goossens M, Rosa J. Hemoglobin. 1984;8:215–228. doi: 10.3109/03630268408996970. [DOI] [PubMed] [Google Scholar]
  • 44.Martínez G, Carnot J, Hernandez P. Hemoglobin. 1983;7:591–594. doi: 10.3109/03630268309027941. [DOI] [PubMed] [Google Scholar]
  • 45.Miranda S R P, Kimura E M, Saad S T O, Costa F F. Hemoglobin. 1994;18:337–342. doi: 10.3109/03630269408996200. [DOI] [PubMed] [Google Scholar]
  • 46.Restrepo A. In: Genetical, Functional, and Physical Studies of Hemoglobins. Arends T, Bemski G, Nagel R, editors. Basel: Karger; 1971. pp. 39–52. [Google Scholar]
  • 47.Rodriguez Romero W E, Castillo M, Chavez M A, Saenz G F, Gu L-H, Wilson J B, Baysal E, Smetanina N S, Leonova J Y, Huisman T H J. Hum Genet. 1996;97:829–833. [PubMed] [Google Scholar]
  • 48.Gonçalves M S, Sonati M F, Kimura E M, Arruda V R, Costa F F, Nechtman J F, Stoming T A. Hemoglobin. 1994;18:337–342. doi: 10.3109/03630269409043625. [DOI] [PubMed] [Google Scholar]
  • 49.Merault G, Keclard L, Saint-Martin C, Jasmin K, Campier A, Delanoe-Garin J, Arous N, Fortune R, Theodore M, Seytor S, et al. FEBS Lett. 1985;184:10–13. doi: 10.1016/0014-5793(85)80642-6. [DOI] [PubMed] [Google Scholar]
  • 50.Rabb L, Serjeant G R. Hemoglobin. 1982;6:403–405. doi: 10.3109/03630268208996946. [DOI] [PubMed] [Google Scholar]
  • 51.Arends T. In: The Ongoing Evolution of Latin American Populations. Salzano F M, editor. Springfield: Charles C. Thomas; 1971. pp. 509–559. [Google Scholar]
  • 52.Naoum P C. Hemoglobinopatias e Talassemias. São Paulo, Brazil: Sarvier; 1997. [Google Scholar]
  • 53.Bardakjian J, Kister J, Rhoda M D, Marden M, Arous N, De Leon J, North M L, Lacombe C, Blouquit Y, Castracane C, et al. Hemoglobin. 1988;12:1–11. doi: 10.3109/03630268808996877. [DOI] [PubMed] [Google Scholar]
  • 54.Sonati M F, Kimura E M, Grotto H Z W, Gervasio S A, Costa F F. Hemoglobin. 1996;20:175–179. doi: 10.3109/03630269609027926. [DOI] [PubMed] [Google Scholar]
  • 55.Miranda M R P, Fonseca S F, Figueiredo M S, Yamamoto M, Grotto H Z W, Saad S T O, Costa F F. Braz J Genet. 1997;20:745–748. [Google Scholar]
  • 56.Passos L N M, Marques H O, Naoum P C, Carrel R W, Williamson R T. Bol Soc Bras Hematol Hemoter. 1998;20,Suppl.:98. [Google Scholar]
  • 57.Miranda S R P, Kimura E M, Teixeira R C, Bertuzzo C S, Ramalho A S, Saad S T O, Costa F F. Hemoglobin. 1996;20:147–154. doi: 10.3109/03630269609027921. [DOI] [PubMed] [Google Scholar]
  • 58.Franco-Gamboa E, Ibarra B, Zuñiga P, Figuero-Peña C L, Cantú J M. In: Proceedings 6th International Congress of Human Genetics. Tamir B B, Cohen T, Goodman R M, editors. New York: Alan R. Liss; 1981. p. 35. [Google Scholar]
  • 59.Arends T, Garlin G, Pérez-Bández O, Anchustegui M. Hemoglobin. 1982;6:243–246. doi: 10.3109/03630268208991701. [DOI] [PubMed] [Google Scholar]
  • 60.Arends T. Gac Med Caracas. 1984;92:189–224. [Google Scholar]
  • 61.Naoum P C, Machado P E A, Michelim O C. Rev Bras Pesq Med Biol. 1976;9:273–278. [PubMed] [Google Scholar]
  • 62.Naoum P C, Mattos L C, Curi P R. Bull Pan Am Health Org. 1984;18:127–138. [PubMed] [Google Scholar]
  • 63.Zago M A, Costa F F. Hemoglobin. 1988;12:399–403. doi: 10.3109/03630268808998040. [DOI] [PubMed] [Google Scholar]
  • 64.Martínez G, Lima F, Colombo B. Biochim Biophys Acta. 1977;491:1–6. doi: 10.1016/0005-2795(77)90034-4. [DOI] [PubMed] [Google Scholar]
  • 65.Sciarrata G V, Ivaldi G, Moruzzi F. Hemoglobin. 1990;14:115–117. doi: 10.3109/03630269009002260. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES